From left, the High Commissioner of India to Canada Ajay Bisaria, a VP at AstraZeneca, Mo Amin, Howard Glase CEO and General manger of Verity Pharmaceuticals, Anita Anand, Canada’s Minister of Public Services and Procurement and Guy Payette, President, Innomar Strategies pose for a photo with some of the first 500, 000 of the 2-million AstraZeneca coronavirus disease (COVID-19) vaccine doses that Canada has secured through a deal with the Serum Institute of India in partnership with Verity Pharma at a facility in Milton, Ontario, Canada March 3, 2021. REUTERS/Carlos Osorio